Koch Labs

Organization

An experimental framework within Koch Industries treating business units as testing grounds for new tech.


First Mentioned

5/19/2026, 5:11:03 AM

Last Updated

5/19/2026, 5:21:06 AM

Research Retrieved

5/19/2026, 5:21:06 AM

Summary

Koch Labs is a specialized internal testing environment and dedicated team within Koch Disruptive Technologies (KDT), the venture capital arm of Koch Industries. It functions as a "laboratory" where portfolio companies can experiment, iterate, and scale their technologies by leveraging Koch Industries' vast global infrastructure, which includes over 500 operations and production units and 475 brands. By providing access to subject matter experts in fields like IT, logistics, legal, and HR, Koch Labs helps entrepreneurs navigate regulatory hurdles and accelerate commercialization. The initiative is a core component of Chase Koch's vision for "permissionless innovation" and has reportedly generated over $300 million in transformational value for its partners.

Referenced in 1 Document
Research Data
Extracted Attributes
  • Core Model

    Koch as a lab

  • Primary Focus

    Accelerating commercialization and innovation for portfolio companies

  • Ultimate Parent

    Koch Industries

  • Key Capabilities

    IT/OT, Human Resources, Legal, Logistics, Global Partner Community

  • Parent Organization

    Koch Disruptive Technologies (KDT)

  • Commercial Value Generated

    Over $300 million

  • Global Infrastructure Access

    500+ operations and production units

Timeline
  • Chase Koch establishes Koch Disruptive Technologies (KDT) to implement the "Koch Laboratory" concept and champion permissionless innovation. (Source: Koch Disruptive Technologies: Who They Are and Why They've Invested Hundreds of Millions in Focused Ultrasound)

    2018-01-01

  • Koch Labs and KDT report generating more than $300 million of commercial and transformational value for portfolio companies over their operating history. (Source: KDT - Koch Labs)

    2023-12-31

Koch snowflake

The Koch snowflake (also known as the Koch curve, Koch star, or Koch island) is a fractal curve and one of the earliest fractals to have been described. It is based on the Koch curve, which appeared in a 1904 paper titled "On a Continuous Curve Without Tangents, Constructible from Elementary Geometry" by the Swedish mathematician Helge von Koch. The Koch snowflake can be built up iteratively, in a sequence of stages. The first stage is an equilateral triangle, and each successive stage is formed by adding outward bends to each side of the previous stage, making smaller equilateral triangles. The areas enclosed by the successive stages in the construction of the snowflake converge to 8 5 {\displaystyle {\tfrac {8}{5}}} times the area of the original triangle, while the perimeters of the successive stages increase without bound. Consequently, the snowflake encloses a finite area, but has an infinite perimeter. The Koch snowflake has been constructed as an example of a continuous curve where drawing a tangent line to any point is impossible. Unlike the earlier Weierstrass function where the proof was purely analytical, the Koch snowflake was created to be possible to geometrically represent at the time, so that this property could also be seen through "naive intuition".

Web Search Results
  • KDT - Koch Labs

    # The Engine That Accelerates Results Koch Labs® is a team of dedicated individuals inside Koch Disruptive Technologies that’s fully focused on connecting our portfolio companies to a diverse ecosystem of subject matter experts, businesses, and capabilities across Koch and our partner community. Our extensive access to a wide range of businesses and global locations provides the entrepreneurs we work with collaboration opportunities that can accelerate innovation and product deployment. In the last 10 years, Koch invested more than $40 billion on technology acquisitions. Koch has more than 500 operations and production units around the world, ranging from energy and consumer goods to paper and electronics. ## Koch Labs® In Action [...] ## Koch Labs® In Action KDT and Koch Labs® have generated more than $300 million of commercial and transformational value for our portfolio companies. Beyond that, we connect them with experts in IT/OT, human resources, legal, and logistics who help them get better results faster. In practice, that looks like enabling our portfolio companies to expand into international markets, save money on enterprise software and cloud services, and navigate complicated legal and regulatory issues at the state, federal, and international levels. Why It Matters With access to our flexible capital, strategic guidance, and global partner community, portfolio companies can quickly expand market presence and accelerate growth. [...] This approach leads to win-win outcomes that create value for our portfolio companies and Koch. Koch owns and manages 475 brands, including many highly recognizable consumer and B2B brands. At any given time, over 30,000 trucks on the road and 16,000 rail cars are hauling Koch goods. ## Our Capabilities Complement Your Specific Needs Whatever you’re trying to accomplish, Koch Labs® can help you. ###### Access to Global Partner Community Find new customers and accelerate growth. ###### Koch Labs® Capabilities Utilize our team of HR, legal, logistics, and IT experts. ###### Accelerated Commercial Delivery Test and iterate ideas in real-world environments to develop applicable solutions faster. ###### Improved Business Performance

  • KDT - Koch Disruptive Technologies

    ## Koch Labs® Koch Labs® is the engine that drives better results for our partners and us. Learn more about how this dedicated team inside KDT connects our portfolio companies to global opportunities. Discover Koch Labs® [...] Koch Disruptive Technologies # Empowering Entrepreneurs We believe technology can improve the world around us. Koch Disruptive Technologies and Koch Labs® help companies drive this positive change by unlocking their potential and accelerating commercialization through our flexible capital, global partner community, and focus on mutual benefit. About Us Koch Labs® Our Vision ## Accelerating Innovation KDT is driven to help principled entrepreneurs with transformative technologies achieve their potential by leveraging mutually beneficial partnerships that enable their companies and Koch to innovate, scale, and generate profitable growth. ## What Makes Us Different ###### Flexible Capital Solutions Financial solutions that adapt to a company’s specific needs. [...] ###### Koch Labs® Capability Access to a diverse ecosystem of subject matter experts, commercial partners, and capabilities. ###### Principle Based Management® Our unique business philosophy enables us to focus on mutually beneficial outcomes and long-term value creation. ## Latest News Explore All Stories At KDT, we're focused on advancing technological breakthroughs like co-packaged optics - optical int At KDT, we're focused on advancing technological breakthroughs like co-packaged optics - optical int Today, we are announcing something big - TOP (Trailer Optimization Platform) - the industry’s first Today, we are announcing something big - TOP (Trailer Optimization Platform) - the industry’s first

  • KDT - About

    Director Koch Labs® ###### Navin Maharaj Sr. Director Koch Labs® ###### Reed Aldridge Associate ###### Spencer Champlin Director ###### Tanner Gonzalez Director Koch Labs® ###### Toni Uhrig Executive Administrative Assistant ###### Trevor Cumpston Analyst ## Koch Labs® Koch Labs® is the engine that drives better results for our partners and us. Learn more about how this dedicated team inside KDT connects our portfolio companies to global opportunities. Discover Koch Labs® [...] # Your Partners in Growth Our expert team is your link to a diverse partner community that can provide your company access to unique capabilities, including Koch Labs®, relevant knowledge, and global commercial deployment opportunities. We’ll support you when and where you need it, helping you accelerate growth and drive better results for everyone in the partnership. Connect with KDT and our team on LinkedIn to explore what we can do together. About Our Founder ## Chase Koch Executive Vice President of Origination and Partnerships, Koch Chase Koch founded Koch Disruptive Technologies to identify and partner with companies with extraordinary potential and apply Koch’s unique philosophy and Vision to help them grow. [...] As executive vice president of Koch, Chase originates new opportunities and preferred partnerships for the company. He is especially focused on helping technology-related and family-owned businesses unlock their potential by bringing the “Koch as a lab” model and mutually beneficial flexible capital solutions to be the preferred partner of choice. ##### Meet The Team ###### Byron Knight President ###### Aliza Goldberg Associate, KDT Israel ###### Brendon Durkin Managing Director ###### Celeste Dauner Managing Director ###### Edward Metelitsa Director ###### Emerson James Director ###### Isaac Sigron Managing Director, KDT Israel ###### Jon Chisholm Managing Director ###### Keaton Goedert Director ###### Nate Purdum Director Koch Labs® ###### Navin Maharaj

  • David H. Koch Institute for Integrative Cancer Research - Tradeline, Inc.

    Courtesy of Ellenzweig The Koch Institute for Integrative Cancer Research is a pioneering research facility that brings together biologists working to understand the disease at a molecular level and engineering faculty devoted to solving problems related to cancer. The ultimate goal is to accelerate the discovery of cures for cancer. The building accommodates 27 research groups and 460 researchers, various support spaces, 15 "core" laboratories, faculty and administrative offices, a 220-seat divisible meeting room, 14 conference rooms, a public café, and a street-level public gallery that displays video and images generated by the MIT cancer research community. The building also includes a below-grade loading facility and tunnel service connections to adjacent buildings. [...] The compact laboratory floors are organized to maximize the interaction of the researchers and opportunities for shared use of both space and research equipment. The research layout features a central, shared laboratory support zone bounded by a “race track” corridor. Bench laboratories on the perimeter enjoy generous daylight. Faculty offices, open lounges, meeting rooms, tea rooms, office support, and vertical circulation are all located at the center of the research floors. This layout generates efficiencies in the researchers’ use of resources, and opportunities for the unplanned, serendipitous encounters that contribute to research advances.

  • Koch Disruptive Technologies: Who They Are and Why They've Invested Hundreds of Millions in Focused Ultrasound - Focused Ultrasound Foundation

    Mr. Koch: We wanted to bring Koch Industries to the most disruptive and transformative founders in the world, and bring that platform as a laboratory for them to experiment in, and to be able to leverage and take our assets, and be able to unlock more value in their company than they otherwise would just taking capital from anyone. So this was the key thesis, this “Koch Laboratory,” to bring it to founders in a way that no other large company had done. [...] Other large companies may have great assets and capabilities, but they struggle to overcome silos in their businesses – sometimes incentives aren’t aligned, they can be slow and bureaucratic, and even try to tie the hands of the founder with exclusivities around the technology. So we said, “How can we create a business within Koch that actually does the opposite of all that and really provides a solution that the market hasn’t seen before?” Then we started KDT in January of 2018 to originate these disruptive and transformative founders and companies, invest in them, and then connect them into Koch through this Koch Laboratory concept. [...] - Breast Tumors - Cancer Pain - Cervical Tumors - Diffuse Intrinsic Pontine Glioma (DIPG)") - Endometrial Tumors - Esophageal Cancer - Glioblastoma - Head and Neck Cancer - Kidney Tumors - Liver Tumors - Lung Tumors - Melanoma - Multiple Myeloma - Neuroblastoma - Ovarian Tumors - Pancreatic Cancer - Prostate Cancer - Sacral Chordomas - Sarcoma - Soft Tissue Tumors - Thyroid Cancer - Vaginal Tumors + Ophthalmological - Blindness - Dry Eye Disease - Glaucoma - Macular Degeneration - Neuromyelitis Optica - Presbyopia - Myopia and Hyperopia - Retinal Injury - Retinal Tumors + Respiratory - COVID (Coronavirus Disease of 2019)") - Lung Tumors